Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps3-22-09 | Nodules 2 | ETA2023

Percutaneous ethanol sclerotherapy for the treatment of benign cystic thyroid nodules: A 5 year-experience at a tertiary care hospital

Carmona Alexandrino Henrique , Ramalho Diogo , Machado Catarina , Jesus Nuno , Ferreira Marta , Rocha Gustavo , Joao Oliveira Maria

Objectives: Assess the efficacy and safety of ultrasound-guided percutaneous ethanol injection (PEI) for treating benign cystic or predominantly cystic-thyroid nodules (TN).Methods: Retrospective analysis of all euthyroid patients treated with PEI for purely (>90% of cystic component) or predominantly cystic (50%-90% of cystic component) TN between January 2018 to February 2023. Efficacy was defined as 50% or greater reduction in pretreatment volume ...

ea0099ep207 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Estimated glucose disposal rate as a predictor of chronic complications in type 1 diabetes – a cross-sectional study

Jesus Nuno , Tavares Patricia , Alexandrino Henrique , Silva Jose , Goncalves Margarida , Sousa Ana , Rocha Gustavo , Ferreira Marta , Correia Sara , Monteiro Sara , Oliveira Maria

Introduction: Insulin resistance, often implicated in the pathophysiology of Type 2 Diabetes Mellitus, can also occur in patients with Type 1 Diabetes Mellitus (T1DM), giving rise to a distinct phenotype that some authors describe as Double Diabetes - a population with a higher risk of developing chronic complications. The estimated glucose disposal rate (eGDR) is a validated marker of insulin resistance in Type 1 Diabetes (T1DM), based on data obtained from the hyperinsulinem...